Advertisement
Home 2016

Archives

Cancer patients who have diabetes may suffer worse heart damage from chemotherapy

Chemo-Related Cardiotoxicity Worse in Diabetes Patients

0
Those with diabetes showed more early warning signs of heart failure
Breast cancer mortality rates are decreasing in the United States and many other countries

SABCS: Breast Cancer Mortality Rates Globally Diverse

0
Many countries seeing declines, but some Latin American nations, South Korea seeing increases
Women taking aromatase inhibitors may show signs of early endothelial dysfunction that could lead to cardiovascular disease

SABCS: Aromatase Inhibitors Tied to Reduced Endothelial Function

0
Women on aromatase inhibitors exhibit less elasticity in their blood vessels
Cooling the scalp with a specialized cap during chemotherapy sessions could help breast cancer patients avoid treatment-related hair loss

SABCS: Scalp-Cooling System Can Reduce Chemo-Related Hair Loss

0
Devices reduce blood flow to hair follicles during chemotherapy treatments
An artificially intelligent computer system

SABCS: Artificial Intelligence May Aid Doctors in Breast Cancer Care

0
'Watson Oncology' agreed with doctors 90 percent of the time in many cases, researchers find
Yoga may help reduce blood pressure in patients who are at risk for developing hypertension

Yoga Helps Control BP in Patients With Prehypertension

0
Patients who added the practice to a healthy lifestyle saw their pressure levels drop
In women with advanced hormone receptor-positive

SABCS: Rx Combo Promising in Advanced HR+, HER2− Breast CA

0
Everolimus added to fulvestrant appears to improve progression-free survival
Some high-risk women who take tamoxifen to prevent breast cancer may mistake naturally occurring nausea and vomiting for side effects of the drug and stop taking it

SABCS: Tamoxifen May Be Unfairly Blamed for Side Effects

0
Perceived side effects might lead some to stop taking the medication, researchers say
Osimertinib is more effective than platinum-pemetrexed therapy in patients with T790M-positive advanced non-small-cell lung cancer whose disease has progressed during first-line epidermal growth factor receptor tyrosine kinase inhibitor treatment

Osimertinib Bests Platinum-Pemetrexed in T790M+ NSCLC

0
Significantly longer duration of progression-free survival with osimertinib vs platinum-pemetrexed
A single dose of an experimental gene therapy may benefit patients with hemophilia B

ASH: Single Dose of Gene Therapy Effective in Hemophilia B

0
Small, preliminary trial suggests it may free hemophilia B patients from transfusions